Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,974 public trials 716 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes

NCT00099944

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals East Hanover, New Jersey, United States

View Trial Details

Completed

Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%

NCT00101673

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals Basel, Switzerland

View Trial Details

Completed

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes

NCT00138619

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals East Hanover, New Jersey, United States

Investigative Centers, Germany

View Trial Details

Completed

Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

NCT00099931

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Investigative Site Investigative Sites, Germany

View Trial Details

Completed

A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes

NCT00351546

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Glycemic Holter Study (Continuous Glucose Monitoring) -

NCT01193296

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Investigative Site Bondy, France

Investigative Site Corbeil, France

Investigative Site Marseille, France

Investigative Site Nancy, France

View Trial Details

Completed

A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes

NCT00099957

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals Basel, Switzerland

View Trial Details

Completed

Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

NCT00572650

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Novartis Investigator Site Kiel, Germany

View Trial Details

Completed

A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

NCT00099905

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals East Hanover, New Jersey, United States

View Trial Details

Completed

A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes

NCT00238498

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Not specified

View Trial Details